Lead Pharmacist and researcher specializing in Population Health Management and Patient-Centered Care to improve chronic disease outcomes and global pharmacy.
|
Level / Type |
Qualification / Focus |
Institution / Body |
|
Primary Degree |
Bachelor of Pharmacy (BPharm) |
Registered Pharmacist (UK) |
|
Postgraduate |
Clinical Pharmacy / Population Health |
Middlesex University / NHS Training |
|
Professional |
Registered Pharmacist |
General Pharmaceutical Council (GPhC) |
|
Specialization |
Population Health Management (PHM) |
NHS Clinical Leadership Programs |
|
Advanced Research |
Patient-Centered Care (PCC) |
Art & Design Research Institute (ADRI) |
|
Continuing Ed |
Independent Prescribing |
Royal Pharmaceutical Society (RPS) |
Thewodros "Theo" Leka is a distinguished Ethiopian-British clinical pharmacist and healthcare innovator. He currently serves as the Lead Pharmacist for the Population Health Management (PHM) Clinic at West Middlesex University Hospital (Chelsea and Westminster Hospital NHS Foundation Trust).
Leka is globally recognized for his pioneering work in integrating PHM into surgical pre-assessment. His data-driven model proactively identifies and treats patients with uncontrolled chronic conditions, such as Type 2 diabetes and hypertension, before they undergo surgery. This intervention significantly improves clinical outcomes, including a documented average HbA1c reduction of 23.2 mmol/mol in his patient cohorts
Population Health Management (PHM): Developing systems to identify high-risk patients using data stratification. He notably integrated PHM into surgical pre-assessment to treat chronic risks (like uncontrolled diabetes) weeks before a patient reaches the operating table.
Patient-Centered Care (PCC): Investigating how the quality of the pharmacist-patient relationship influences clinical outcomes. His research proves that when patients feel "empowered" rather than "passive," their health improves significantly.
Medication Adherence & Psychology: Studying the "Beliefs about Medicines" (BMQ). His work demonstrates that effective communication increases a patient’s perceived necessity of a drug while decreasing concerns about its potential harm.
Chronic Disease Intervention: Quantitative research into pharmacist-led clinics for Type 2 Diabetes Mellitus (T2DM) and Hypertension, measuring specific markers like HbA1c reduction and blood pressure stabilization.
|
Activity |
Impact & Key Findings |
|
Surgical PHM Clinic |
Integrated a clinic into hospital pre-assessment to treat chronic risks (diabetes/hypertension) weeks before surgery. |
|
HbA1c Reduction |
Documented a significant mean decrease of 23.2 mmol/mol in diabetic patients through pharmacist-led care. |
|
Blood Pressure Control |
Achieved reductions of 27.5 mmHg (systolic) and 9.1 mmHg (diastolic) in high-risk cohorts. |
|
Adherence Psychology |
Proved that PCC increases a patient’s "belief in necessity" while lowering "concerns about harm" regarding medication. |
|
Weight Management |
90% of patients in his community programs achieved a 5–10% reduction in BMI. |
|
Global Pharmacy |
Founded PAMECO to conduct research and training on rational drug use in Ethiopia, Kenya, and Sudan. |
Impact of patient-centred care and population health management on diabetes and hypertension outcomes
Establishing a Population Health Management Clinic (PHMC) in surgical pre-assessment unit at WMUH
Does patient centred care practice improve medication adherence of patients with type 2 diabetes mellitus?
Raised APTT in hospitalised patients with renal impairment: causes and association with low molecular weight heparin (LMWH)
Raised APTT in hospitalised patients with renal impairment: causes and association with low molecular weight heparin (LMWH)